Explain this page
Arphra AIPlain-English read on Colgate-Palmolive Company’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +59.08% | +56.49% | +57.82% | +60.23% | +60.11% | +59.00% | +58.11% | +59.72% | +60.66% |
| Operating margin | +22.31% | +19.95% | +21.23% | +21.80% | +21.33% | +20.89% | +21.56% | +21.70% | +21.34% |
| EBITDA margin | +21.58% | +18.77% | +21.82% | +24.14% | +19.41% | +21.35% | +21.32% | +21.87% | +21.81% |
| EBIT margin | +18.39% | +15.73% | +18.91% | +21.13% | +16.32% | +18.95% | +19.32% | +18.64% | +18.98% |
| Pre-tax margin | +17.72% | +14.80% | +17.43% | +19.68% | +15.01% | +17.36% | +17.71% | +17.30% | +17.60% |
| Net margin | +12.43% | +9.93% | +11.82% | +14.37% | +10.46% | +12.53% | +11.97% | +12.35% | +12.25% |
| Cost structure | |||||||||
| Cost of revenue / sales | +40.92% | +43.51% | +42.18% | +39.77% | +39.89% | +40.66% | +40.01% | +39.91% | +39.60% |
| R&D intensity | +1.76% | +1.78% | +1.76% | +1.77% | 0.00% | +1.20% | +1.19% | +1.17% | +1.17% |
| SG&A intensity | +35.02% | +34.76% | +34.83% | +38.85% | +38.77% | +37.08% | +37.20% | +37.74% | +38.01% |
| Effective tax rate | +24.26% | +26.05% | +27.62% | +22.93% | +26.09% | +26.21% | +25.73% | +25.95% | +25.32% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +223.07% | +221.46% | +240.33% | +531.07% | +584.11% | +400.33% | +375.77% | +404.80% | +383.54% |
| Return on assets (ROA) | +14.40% | +11.35% | +14.03% | +18.00% | +13.06% | +15.04% | +14.98% | +15.53% | +14.77% |
| Return on capital (ROC) | +44.14% | +35.58% | +41.22% | +48.40% | +52.05% | +45.28% | +46.93% | +46.53% | +46.86% |
| Return on invested capital (ROIC) | +24.60% | +17.71% | +22.95% | +31.90% | +25.52% | +27.16% | +26.05% | +26.49% | +26.90% |
| Asset turnover | +115.83% | +114.21% | +118.69% | +125.27% | +124.81% | +120.02% | +125.14% | +125.71% | +120.58% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +12.43% | +9.93% | +11.82% | +14.37% | +10.46% | +12.53% | +11.97% | +12.35% | +12.25% |
| Asset turnover (× revenue / assets) | +115.83% | +114.21% | +118.69% | +125.27% | +124.81% | +120.02% | +125.14% | +125.71% | +120.58% |
| Equity multiplier (× assets / equity) | +1548.92% | +1951.74% | +1712.96% | +2949.63% | +4473.97% | +2661.82% | +2508.14% | +2606.74% | +2596.77% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 1.16 | 1.14 | 1.19 | 1.25 | 1.25 | 1.20 | 1.25 | 1.26 | 1.21 |
| Fixed-asset turnover | 4.67 | 4.17 | 4.25 | 4.55 | 4.37 | — | — | — | — |
| Inventory turnover | 4.21 | 3.77 | 4.24 | 4.02 | 4.00 | — | — | — | — |
| Receivables turnover | 13.43 | 11.95 | 12.27 | 13.22 | 12.17 | — | — | — | — |
| Payables turnover | 4.82 | 5.04 | 4.83 | 4.43 | — | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 27.17 | 30.55 | 29.75 | 27.62 | 30.00 | — | — | — | — |
| Days inventory outstanding (DIO) | 86.64 | 96.84 | 86.02 | 90.71 | 91.22 | — | — | — | — |
| Days payables outstanding (DPO) | 75.73 | 72.42 | 75.53 | 82.40 | — | — | — | — | — |
| Cash conversion cycle | 38.08 | 54.97 | 40.25 | 35.93 | 121.21 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.54 | 1.43 | 1.63 | 1.42 | 1.97 | 1.57 | 1.64 | 1.64 | 1.68 |
| FCF / Net income | 1.27 | 1.04 | 1.32 | 1.23 | 1.70 | 1.36 | 1.41 | 1.34 | 1.36 |
| FCF margin | +15.83% | +10.35% | +15.62% | +17.64% | +17.83% | +17.00% | +16.87% | +16.53% | +16.68% |
| OCF margin | +19.09% | +14.23% | +19.25% | +20.43% | +20.60% | +19.70% | +19.67% | +20.29% | +20.58% |
| CapEx / Revenue | +3.25% | +3.87% | +3.62% | +2.79% | +2.77% | +3.08% | +3.08% | +3.06% | +3.10% |
| CapEx / D&A | 1.02 | 1.28 | 1.24 | 0.93 | 0.90 | — | — | — | — |
| Stock-based comp / Revenue | +0.77% | +0.70% | +0.63% | +0.67% | 0.00% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 2.55 | 2.13 | 2.77 | 3.51 | 2.63 | 3.80 | 4.01 | 4.31 | 4.64 |
| EPS · basic | 2.56 | 2.13 | 2.78 | 3.53 | 2.64 | 3.81 | 3.99 | 4.30 | 4.69 |
| Book value / share | 1.14 | 0.96 | 1.15 | 0.66 | 0.45 | 0.83 | 0.88 | 0.86 | 0.93 |
| Tangible BV / share | -5.63 | -5.32 | -5.23 | -5.45 | -5.29 | 0.83 | 0.88 | 0.86 | 0.93 |
| Sales / share | 20.54 | 21.42 | 23.46 | 24.44 | 25.13 | 26.50 | 27.64 | 28.14 | 29.01 |
| Operating CF / share | 3.92 | 3.05 | 4.52 | 4.99 | 5.18 | 5.22 | 5.43 | 5.71 | 5.97 |
| Free cash flow / share | 3.25 | 2.22 | 3.67 | 4.31 | 4.48 | 4.50 | 4.66 | 4.65 | 4.84 |
| Dividends / share | 1.98 | 2.02 | 2.11 | 2.18 | 2.25 | 2.33 | 2.54 | 2.57 | 2.67 |
| Payout ratio | +77.52% | +94.73% | +76.04% | +61.92% | +85.51% | +70.26% | +76.71% | +73.90% | +75.14% |
| Retention ratio | +22.48% | +5.27% | +23.96% | +38.08% | +14.49% | +29.74% | +23.29% | +26.10% | +24.86% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +3.13% | +8.29% | +3.31% | +1.40% | +5.37% | +3.33% | +3.57% | +2.52% | +3.85% |
| Gross profit · YoY | — | -1.39% | +10.85% | +7.60% | +1.20% | +3.44% | +1.77% | +6.42% | +4.13% | +4.19% |
| Profit | ||||||||||
| Operating income · YoY | — | -7.75% | +15.23% | +6.10% | -0.80% | +3.17% | +6.68% | +4.23% | +0.79% | +3.27% |
| EBITDA · YoY | — | -10.32% | +25.92% | +14.30% | -18.48% | +15.91% | +3.19% | +6.25% | +2.23% | +3.98% |
| Net income · YoY | — | -17.59% | +28.85% | +25.61% | -26.20% | +26.23% | -1.28% | +6.87% | +1.66% | +3.65% |
| Operating | ||||||||||
| EBIT · YoY | — | -11.77% | +30.14% | +15.47% | -21.70% | +22.39% | +5.35% | -0.13% | +4.43% | +4.26% |
| R&D · YoY | — | +4.23% | +7.19% | +3.50% | -100.00% | — | +2.41% | +1.67% | +2.65% | -1.34% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | -16.47% | +30.05% | +26.71% | -25.07% | +44.54% | +5.41% | +7.45% | +7.76% | +7.77% |
| EPS · basic · YoY | — | -16.80% | +30.52% | +26.98% | -25.21% | +44.40% | +4.72% | +7.79% | +9.05% | +7.87% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $7.83B | $9.27B | $9.06B | $8.51B | $7.99B | $9.24B | $9.49B | $10.02B | $9.98B |
| Net debt | $7B | $8.5B | $8.1B | $7.42B | $6.7B | $8.06B | $8.27B | $8.73B | $8.7B |
| Net debt / EBITDA | 1.86 | 2.52 | 1.91 | 1.53 | 1.69 | 1.76 | 1.75 | 1.74 | 1.69 |
| Debt / equity | 8.07 | 11.50 | 9.47 | 15.65 | 21.88 | 13.74 | 13.42 | 14.28 | 13.26 |
| Debt / assets | +52.08% | +58.93% | +55.29% | +53.05% | +48.92% | +51.61% | +53.52% | +54.79% | +51.05% |
| Equity / assets | +6.46% | +5.12% | +5.84% | +3.39% | +2.24% | +3.76% | +3.99% | +3.84% | +3.85% |
| Coverage | |||||||||
| EBITDA / interest expense | 32.14 | 20.19 | 14.79 | 16.62 | 14.82 | 14.91 | 14.67 | 15.28 | 15.71 |
| Operating income / interest | 33.21 | 21.47 | 14.39 | 15.01 | 16.28 | 14.59 | 14.84 | 15.16 | 15.37 |
| Interest expense | $117M | $167M | $287M | $292M | $267M | $307.49M | $322.45M | $329.06M | $327.14M |
| Liquidity | |||||||||
| Current ratio | 1.09 | 1.28 | 1.11 | 0.92 | 1.00 | — | — | — | — |
| Quick ratio | 0.53 | 0.57 | 0.54 | 0.48 | 0.52 | — | — | — | — |
| Cash ratio | 0.21 | 0.19 | 0.20 | 0.19 | 0.22 | — | — | — | — |
| Working capital | $346M | $1.11B | $538M | -$442M | -$27M | — | — | — | — |
| Working capital / revenue | +1.99% | +6.17% | +2.77% | -2.20% | -0.13% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).